NARA Discovery
Article Details
← Back to Search Results
Journal Article

Life cycle, host specificity and potential impact of a gall-inducing thrips Acaciothrips ebneri, a biological control agent for prickly acacia (Vachellia nilotica subsp. indica) in Australia

Boyang Shi; Kunjithapatham Dhileepan
BioControl · Vol. 69, Issue 6 · pp. 699-712 · 2024

Abstract

Prickly acacia ( Vachellia nilotica subsp. indica (Benth.) Kyal. & Boatwr.; Fabales: Fabaceae) is a Weed of National Significance and a target for biological control in Australia. Currently there are no effective biological control agents for the weed in Australia. Based on genetic and climate matching, a gall thrips ( Acaciothrips ebneri Karny; Thysanoptera: Phlaeothripidae) inducing rosette galls resulting in shoot tip dieback, was identified as a prospective biological control agent from Ethiopia. No-choice host-specificity tests were conducted on 59 test plant species in a high security quarantine in Brisbane, Australia. Acaciothrips ebneri is host-specific, inducing galls and reproducing only on prickly acacia. Acaciothrips ebneri , as predicted by the CLIMEX model, is suited to hot and arid western Queensland where major prickly acacia infestations occur. The Australian Government approved A. ebneri for field release in October 2022. This is the first time a true gall-inducing thrips has ever been approved as a weed biological control agent. Field releases commenced in January 2023 and are in progress. There are early signs of field establishment resulting in shoot tip die back in the field, and field release and monitoring will continue.

Bibliographic Information

JournalBioControl
PublisherSpringer
Publication Date2024-12-01
Publication Year2024
Volume69
Issue6
Pages699-712
Document TypeJournal Article
Print ISSN1386-6141
eISSN1573-8248
DOI10.1007/s10526-024-10269-y

Access Information

NARA Access Coverage1956-01-01~Current
Journal Homepagehttps://www.springer.com/journal/10526
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.